試題詳解

78. 關於 HCC radioembolization(TARE)or Selective internal radiation therapy(SIRT)的敘述，下列何者正確？
(1) There was no significant difference in OS between sorafenib and TARE in SIRveNIB and SARAH studies for advanced HCC
(2) Current data demonstrate benefit of TARE compared to sorafenib in patients with advanced HCC
(3) Compared to TACE, SIRT provides significantly longer time to progression and better tumor control, but it does not provide longer survival
(4) SIRT might prepare or select patients for surgery as it induces substantial hypertrophy in the liver lobe contralateral to the target
(A) (2)
(B) (1)＋(2)＋(3)
(C) (2)＋(3)＋(4)
(D) (1)＋(2)＋(3)＋(4)

(E) (1)＋(3)＋(4)